CION Ameerpet
Types of Immunotherapy Explained · How the Side Effects Happen
How Immunotherapy Actually Causes Side Effects — The Mechanism, in Plain Language
Immunotherapy does not attack the cancer the way chemotherapy does. It takes the brake off your own immune system and lets it act. That is why it can work, and it is exactly why it can inflame an organ that has nothing to do with your cancer. Understand this one mechanism and every side effect, every monitoring blood test and every warning you have been given stops feeling random.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- It is not a poison — the drug does not damage tissue itself; it removes a checkpoint signal that was holding your own T cells back.
- Why healthy organs are involved — the brake is not tumour-specific, so tolerance of your own tissue falls at the same time as the anti-tumour response rises.
- Why almost any organ — T cells circulate everywhere, so skin, thyroid, bowel, liver, lung, heart and nerves can all be affected.
- Why it is unpredictable — no routine test forecasts who reacts or when, and a reaction can begin months after the last dose. Report early.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The short answer
Why does immunotherapy cause side effects?
Because it does not attack the cancer directly. It removes a brake that normally stops your own T cells from acting against your own tissue. Those unbraked T cells find the tumour. They can also find healthy organs. The side effect is inflammation caused by your immune system, not damage caused by the drug.
Hold on to that sentence, because everything else on this page follows from it. Chemotherapy is a poison aimed at fast-dividing cells, so its side effects are the drug’s own doing. Immunotherapy is closer to an instruction: it changes what your immune system is permitted to attack, then steps back. What happens next is your immune system’s work, not the molecule’s. So the reaction is not tied to the dose number, does not reliably settle when treatment pauses, and is treated by calming the immune response rather than by waiting for a drug to clear.
Before the explanation: what not to wait on
Most immune reactions are mild. A few become dangerous within hours. These are not to be managed at home, and not to be watched overnight.
- Go to the nearest emergency department now for chest pain, palpitations or sudden breathlessness; four or more loose motions a day above your normal, or blood in the stool; severe abdominal pain; new confusion, severe headache with vomiting, fainting or collapse; a drooping eyelid, double vision or difficulty swallowing.
- Call CION on 1800 202 8726 for anything new, persistent or worsening, however small it seems. Early reactions are far easier to control than late ones.
Tell whoever sees you that you are on immunotherapy, and use that word. An emergency doctor who does not know it will treat a serious immune reaction as an ordinary infection. Never start, stop or adjust steroids on your own.
Did you know?
An immunotherapy side effect is inflammation, not poisoning. That is why it is treated with medicines that calm the immune system rather than by flushing the drug out — and why a reaction can begin weeks after a dose, when most of the drug has already gone. The immune change outlasts the medicine that started it.
The mechanism
Why does immunotherapy attack healthy organs?
Because the brake it removes is not tumour-specific. Checkpoint proteins are your body’s way of telling immune cells to leave normal tissue alone, and that instruction is used all over the body. Block the signal and tolerance falls everywhere, not only around the tumour. T cells that were always mildly self-reactive are now free to act.
Your immune system spends every day of your life not attacking you, and that restraint is active rather than accidental. T cells that react strongly against your own tissue are deleted during development, but weakly self-reactive ones survive and circulate harmlessly for decades, held back by checkpoint signals. Checkpoint immunotherapy switches off part of that restraint so the anti-tumour response can build. The weakly self-reactive cells are released at the same time. There is no way to release one group and not the other.
A second mechanism adds to it. Tumours arise from your own cells, so tumour proteins often resemble proteins in healthy tissue, and a response correctly aimed at the cancer can spill over onto an organ that shares a similar-looking protein. Thyroid, skin and bowel lining are common places for that overlap to show. Neither mechanism means something has gone wrong: both are the predictable cost of removing a safety brake, which is why ASCO, ESMO and NCCN publish detailed management pathways for immune-related adverse events rather than treating them as complications.
Immunotherapy is administered as day care at CION centres, so you come in, are treated and go home the same day. Response-assessment imaging such as PET-CT is coordinated at partner imaging centres, not owned by CION.
Where reactions appear
Can immunotherapy affect any organ in the body?
In principle, yes. T cells travel through blood into every tissue, so inflammation can appear almost anywhere. In practice a few sites account for most reactions: skin, thyroid, bowel, liver and lungs. Rarer reactions in the heart, nerves and adrenal glands matter most, because they escalate fastest.
Use the pattern below to recognise a symptom, never to decide whether it is worth reporting. Onset windows are typical, not rules, and any of these reactions can begin outside its usual window, including weeks or months after your final dose.
| Organ or system | What the reaction is called | Typically starts | How it usually shows itself |
|---|---|---|---|
| Skin | Immune-related rash, itching | 2 to 6 weeks — usually the first thing to appear | Itchy rash on the trunk and limbs; occasionally blistering or mouth ulcers, which is not mild |
| Bowel and colon | Immune-related colitis | 5 to 10 weeks | An increase in loose motions above your own normal, cramping, urgency, mucus or blood |
| Thyroid | Thyroiditis, then an underactive thyroid | 4 to 12 weeks | Often no symptoms at first; picked up on routine blood tests before you feel anything |
| Liver | Immune-related hepatitis | 6 to 14 weeks | Usually silent and found on pre-cycle blood tests; sometimes yellow eyes or dark urine |
| Lungs | Immune-related pneumonitis | 8 to 14 weeks, but possible at any point | A dry cough, breathlessness on stairs you managed last week, chest tightness |
| Pituitary and adrenal glands | Hypophysitis, adrenal insufficiency | 8 to 12 weeks, and often later | Profound tiredness, headache, dizziness on standing, nausea, low blood pressure |
| Heart | Immune-related myocarditis | Rare, and usually within the first 6 weeks | Chest pain, palpitations, breathlessness at rest — an emergency the same hour |
| Nerves and muscles | Neuropathy, myositis, myasthenic syndromes | Variable, weeks to many months | Weakness, drooping eyelid, double vision, difficulty swallowing, muscle pain |
| Joints, kidneys, eyes | Arthritis, nephritis, uveitis | Variable, commonly after 8 weeks | Joint pain and stiffness, falling urine output, a red or painful eye with blurred vision |
One figure is worth knowing and no more. Immune-related adverse event guidance published by ASCO, ESMO and NCCN describes some degree of immune-related side effect in a majority of people on a checkpoint inhibitor, and severe reactions in roughly one in ten on a single agent, more often when two are combined. Indicative, as of August 2026. Your own risk is not a percentage.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Know What Your Body Is Telling You
A 45-minute consultation, a tumour-board-reviewed plan, and a written list of the symptoms that need a call, a clinic visit, or an emergency department.
How each class works
Do different types of immunotherapy cause side effects in different ways?
Yes. The class decides the pattern. Checkpoint inhibitors release a brake, so the result is delayed, organ-specific inflammation. Cytokine treatments and T-cell engagers press the accelerator instead, so the result is an early, whole-body reaction with fever and low blood pressure. One immune system, two very different failure modes.
| Class | What it does to the immune system | Why that produces side effects | Typical pattern |
|---|---|---|---|
| PD-1 and PD-L1 inhibitors | Block the checkpoint signal that tissues use locally to switch off arriving T cells | Tolerance falls in tissue, so T cells already present in an organ become active there | Delayed, organ-by-organ inflammation. Thyroid, skin, bowel, liver and lung most often |
| CTLA-4 inhibitors | Act earlier and further upstream, in lymph nodes, on which T cells get licensed at all | A broader set of T cell clones is released, including more self-reactive ones | Reactions tend to arrive earlier and involve more sites, with bowel, skin and endocrine glands prominent |
| Two checkpoint inhibitors combined | Releases both the upstream and the local brake at once | The two effects add together rather than cancel | Severe reactions are more frequent and start sooner, so monitoring is tighter |
| Cytokine therapies (interferon- and interleukin-based) | Flood the body with immune signalling molecules instead of removing a brake | Every cell that can read those signals responds, all at once | Early, whole-body: fever, chills, flu-like aching, low blood pressure, fluid leaking into tissue |
| Bispecific T-cell engagers | Physically clamp a T cell onto a tumour cell to force contact | Mass simultaneous T cell activation releases a surge of cytokines | Cytokine release syndrome and neurological effects, typically in the hours to days after a dose |
| CAR-T and other cell therapies | The patient’s own T cells are re-engineered outside the body and given back | The engineered cells multiply inside the body and can activate en masse | Cytokine release syndrome and neurotoxicity, managed only in specialised inpatient units |
| Cancer vaccines and oncolytic therapies | Present a target to the immune system, or infect tumour cells to provoke a response | The response is deliberately local and comparatively contained | Injection-site reactions and short flu-like symptoms most often |
CION does not provide CAR-T or cell therapy. Where a treating team believes cell therapy should be considered, patients are referred to centres that offer it, and that row is included here for orientation only.
Two companion pages go deeper into the checkpoint classes: PD-1 and PD-L1 Inhibitors: What the Difference Is sets out where each one acts, and CTLA-4 Inhibitors and Why They Are Combined With Others explains why the upstream brake is released alongside the local one. If your prescription has moved to a similar product from another manufacturer, Biosimilars: Are They the Same as the Original Product? covers what does and does not change.
The honest part
Why are immunotherapy side effects so unpredictable?
Because nothing measured before treatment reliably predicts them. No blood test, scan or biomarker in routine use tells us who will react, which organ will be involved, or when. Risk is shaped by your own immune repertoire, which is unlike anyone else’s. So the guidance is to watch and report early, not to screen.
- No predictive test exists in routine practice. Research into markers that might forecast a reaction is active, but the evidence is not mature enough to act on.
- Your immune repertoire is unique. Which T cell clones survived your development, and how strongly they recognise your tissue, is individual to you. That is the main variable, and it is not measurable in clinic.
- A pre-existing autoimmune tendency raises the odds without deciding them. Thyroid disease, psoriasis, rheumatoid arthritis or inflammatory bowel disease in your history matters, and your oncologist needs to know. Many people with no such history still react.
- Timing is not tied to the dose number. A reaction can begin after the first infusion, after a year of uneventful cycles, or weeks to months after the last dose.
- Combinations change the picture. Two checkpoint inhibitors together, or immunotherapy alongside chemotherapy or radiation, shifts both how often reactions occur and how soon.
- Other host factors are being studied. Gut bacteria, prior infections and genetic background have all been proposed. None is established well enough to change practice today.
Where the evidence is genuinely immature, the right answer is to say so. Long-term outcomes after an immune reaction, the effect on fertility, and what happens decades later are areas where the honest answer is that we do not yet know. Be cautious of any source that sounds more certain than the guidelines do.
Did you know?
A reaction can start after your last dose. These antibodies clear slowly, and the change they make to immune tolerance outlasts the drug itself. Months after finishing, a new symptom still needs to be reported as an immunotherapy problem — and every doctor who sees you still needs to be told you had it.
What the mechanism means for you
What should you actually do with this?
Five things, and none of them involve predicting anything. Report early. Say the word immunotherapy to every doctor. Keep a simple daily note. Leave steroid decisions to your team. And know which symptoms belong in an emergency department rather than in a message.
- 1
Report anything new early, even when it seems trivial
A mild reaction caught early is usually straightforward to control. The same reaction three weeks later, ignored because it seemed small, often is not. There is no such thing as calling too soon.
- 2
Tell every doctor you see that you are on immunotherapy
Emergency doctors, physicians, surgeons, dentists. A doctor who does not know will treat immune colitis as gastroenteritis and immune pneumonitis as a chest infection. Carry your treatment card and hand it over.
- 3
Keep one line a day
Loose motions against your own normal, temperature, whether stairs are harder than last week, any new rash. Four dated lines are worth more than a description from memory.
- 4
Never start, stop or adjust steroids yourself
Steroids are the main treatment for a significant immune reaction, and both the dose and the taper are clinical decisions. Stopping early can let the reaction rebound. Someone else’s leftover prescription is not a plan.
- 5
Know the short list that means going in now
Chest pain, palpitations or sudden breathlessness. Four or more loose motions a day above your normal, or blood in the stool. Severe abdominal pain. Collapse, new confusion or a severe headache with vomiting. A drooping eyelid, double vision or difficulty swallowing. Go to the emergency department, and say you are on immunotherapy.
Choosing not to start, or to stop, is a real and legitimate option. If the balance of benefit and risk does not feel right to you, that belongs in a conversation with your oncologist rather than in a quietly missed cycle. CION reviews treatment decisions at a tumour board, and you may ask for the alternatives to be laid out beside the recommendation.
Explained, not glossed over
You Deserve to Know What Is Happening Inside You
We explain the mechanism, the monitoring and the warning signs before treatment starts, so nothing that happens later comes as a shock.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Immunotherapy Side Effects: Your Questions Answered
Why does immunotherapy cause side effects?
Because it does not attack the cancer itself. Checkpoint immunotherapy blocks a protein that normally tells your own T cells to stand down. With that brake released, the T cells act more strongly against the tumour, and they can also act against normal tissue. The side effect is inflammation produced by your own immune system, not chemical damage produced by the drug. That distinction explains the rest: why these reactions are treated with medicines that calm immune activity rather than by flushing the drug out, and why one can begin weeks after a dose. Guideline bodies including ASCO, ESMO and NCCN group them together as immune-related adverse events.
Why does immunotherapy attack healthy organs and not just the cancer?
Because the brake it removes is not specific to the tumour. Checkpoint proteins are the body's general instruction to immune cells to leave normal tissue alone, and that instruction is used all over the body. Blocking the signal lowers tolerance everywhere. T cells that were always mildly reactive against your own tissue, and were previously held in check, are now able to act. Some tumours also carry proteins that closely resemble proteins in healthy tissue, so a response aimed at the cancer can spill over onto the organ that shares them. Neither mechanism means the treatment has gone wrong.
Can immunotherapy side effects affect any organ?
In principle yes, because T cells circulate through the blood into every tissue. In practice a small number of sites account for most reactions: skin, thyroid, bowel, liver and lungs. Joints, kidneys, eyes, nerves, muscles, the pituitary and adrenal glands and the heart are affected far less often. Rarity is not the same as low importance. Inflammation of the heart muscle, of the nerves controlling breathing and swallowing, and of the adrenal glands is uncommon but escalates quickly, which is why chest pain, sudden breathlessness, drooping eyelids, difficulty swallowing, collapse or new confusion are emergency-department problems the same hour.
Why are immunotherapy side effects so unpredictable?
Because nothing measured before treatment reliably predicts them. There is no blood test, scan or biomarker in routine use that says who will react, which organ will be involved, or when. Risk is shaped by your own immune repertoire, which is unlike anyone else's, and by factors such as a pre-existing autoimmune tendency that raise the odds without deciding the outcome. Timing is equally loose. Skin reactions tend to be early and endocrine ones later, but a reaction can begin after the first dose, after a year of uneventful treatment, or weeks to months after the last one.
How are immunotherapy side effects different from chemotherapy side effects?
They come from a different mechanism and follow a different clock. Chemotherapy damages rapidly dividing cells, so its effects are largely predictable, dose-linked and worst in the days after an infusion, then settle before the next cycle. Immunotherapy effects are inflammation driven by your own immune system, so they are not tied to dose number, can start weeks or months in, and can appear after the last dose. Chemotherapy side effects usually improve when treatment pauses. An immune reaction often needs medicines that actively suppress the immune response, prescribed and supervised by your oncology team.
Do immunotherapy side effects mean the treatment is working?
Not reliably, and it is not safe to think that way. Some published analyses report an association between certain immune reactions and treatment response, but it is not strong enough to tell any individual anything useful. Plenty of people benefit without a single reaction, and plenty have a reaction without benefit. Whether treatment is working is answered by response-assessment imaging and your oncologist's review, not by how unwell you feel. The practical risk of the belief is that people tolerate a worsening symptom because they read it as a good sign. Report every new symptom early.